The EEA1 Knockout DLD-1 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal knockout cell population targeting the EEA1 gene in the DLD-1 human colorectal adenocarcinoma epithelial line. This heterogeneous pool of cells harbors gene disruptions that collectively ablate EEA1 protein expression, creating a versatile loss-of-function model for studying endosomal trafficking without clonal selection.
DLD-1 is a well-validated epithelial tumor cell line derived from a male colorectal adenocarcinoma patient, featuring oncogenic mutations in APC (truncating), TP53 (loss-of-function), KRAS (G13D), and PIK3CA (activating), and classified as microsatellite stable. These genetic alterations drive constitutive activation of the KRAS/MAPK and PI3K/AKT pathways, making DLD-1 a representative model for aggressive colorectal cancer with intact DNA mismatch repair.
EEA1 encodes a 180 kDa peripheral membrane protein that functions as a Rab5 effector and PI3P sensor, orchestrating early endosome tethering and fusion. Its recruitment to nascent endosomes requires concurrent binding to GTP-bound RAB5 (RAB5A/B) and PI3P, generated by the lipid kinase VPS34. EEA1 engages SNARE proteins such as syntaxin-6 (STX6) and interacts with RABEP1, RAB22A, WASL, and SNX1 to promote homotypic endosome fusion, a process essential for maintaining endosomal identity and cargo progression. Consequently, EEA1 influences trafficking of internalized receptors??including the EGF and insulin receptors??and modulates downstream effector pathways, notably mTORC1 and MAPK signaling, while also intersecting with autophagic maturation at the endosome level.
In the DLD-1 colorectal cancer background, disrupting EEA1 creates a scenario where endosomal mis?trafficking compounds the existing oncogenic drive. Impaired early endosome fusion leads to prolonged receptor signaling or aberrant compartmentalization, potentially rewiring pathway outputs that rely on spatiotemporal control of activated receptors. Moreover, given the importance of endosomal sorting for nutrient sensing and autophagy, EEA1 knockout may reveal vulnerabilities related to metabolic adaptation and drug resistance in KRAS/PI3K?mutated colorectal tumors.
Typical experimental applications with these polyclonal cells include immunofluorescence analysis of endosomal markers, transferrin?uptake kinetics to measure recycling, Western blotting for pathway phosphorylation status, and co?immunoprecipitation to probe disrupted protein interactions. This tool enables systematic investigation of early endosome dysfunction on colorectal cancer cell proliferation, migration, and sensitivity to kinase inhibitors, as well as dissection of autophagy flux under nutrient stress. For further technical details, assay protocols, or guidance, please contact Ascent Research.
